Bionomics to Present at Biotech Showcase™ 2024
ADELAIDE, Australia and CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq:BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that it will be presenting at the Biotech Showcase™ 2024 taking place January 8-10 in San Francisco, California.
Related news for (BNOX)
- 24/7 Market News Snapshot 08 November, 2024 – Bionomics Limited American Depository Shares (NASDAQ:BNOX)
- 24/7 Market News Snapshot 07 November, 2024 – Bionomics Limited American Depository Shares (NASDAQ:BNOX)
- Bionomics Receives AUS$1M Milestone Payment from Carina Biotech
- 24/7 Market News Snapshot 04 November, 2024 – Bionomics Limited American Depository Shares (NASDAQ:BNOX)
- Bionomics Reports Successful End-of-Phase 2 Meeting with the FDA for BNC210 in Post-Traumatic Stress Disorder
